Anti-Viral Metabolites from Medicinal Plants / edited by Dilipkumar Pal
Chapter 1 Introduction of medicinal plants as source of anti-viral metabolite(s), effects on health and general adverse effects -- Chapter 2:General plants showing anti-viral activity giving emphasis on CDRI’s biological screening programme -- Chapter 3: Classification of medicinal plants having anti-viral activity as per (i) family and (ii) types of viral infections -- Chapter 4: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 1 infections -- Chapter 5: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 2 infections -- Chapter 6: Role of various medicinal plants against in HIV infection in human with possible mechanism of action and functions of secondary metabolites -- Chapter 7: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of different medicinal plants against Hepatitis B infections -- Chapter 8: Antiviral effects of different medicinal plants against Hepatitis C (HCV) infection: Role of phytochemicals -- Chapter 9: Medicinal plants in controlling Pox virus affections:Ethnopharmacology, chemistry, clinical, preclinical studies and future perspectives -- Chapter 10: Role of medicinal plants in prevention and treatment of Respiratory viral infections -- Chapter 11: Assessment of effectiveness of herbal drugs in prevention and treatment against Gastrointestinal viral diseases -- Chapter 12: Antiviral potential of medicinal plants in treatment of diseases caused by Influenza virus A: Role of secondary metabolites, clinical and preclinical studies and future perspectives -- Chapter 13: Role of medicinal plants in treatment of diseases caused by Influenza virus B and Parainfluenza virus type 3 -- Chapter 14: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on the uses of herbal drugs against Polio Infections -- Chapter 15: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of medicinal plants against SARS-CoV/Corona virus infections -- Chapter 16: Medicinal plants in controlling and treatment of diseases caused by Viral Haemorrhagic Septicaemia Virus (VHSV) -- Chapter 17:Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against vesicular stomatitis virus (VSV) infections -- Chapter 18: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of various medicinal plants against Human Adenovirus Type 1 infections -- Chapter 19: Medicinal plants used by traditional medical practitioner in controlling and treatment of Cutaneous viral diseases: Ethnopharmacology, chemistry, Clinical and preclinical studies -- Chapter 20: Herbal drugs and medicinal plants in controlling and treatment for the diseases caused by Dengue virus (DEN-1 & 2): Ethnopharmacology, chemistry, clinical and preclinical studies -- Chapter 21: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of natural medicinal plants against Neurological viral diseases -- Chapter 22: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on traditional crude drugs against Encephalitis infection -- Chapter 23: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use natural plants in the treatment of Renal syndrome caused by viruses -- Chapter 24: Natural products in controlling and treatment of cancers and genital warts caused by different viruses -- Chapter 25: Role of traditional plants in controlling and treatment of fever, joint pain and pogosta diseases caused by viruses -- Chapter 26: Natural medicinal plants used in in controlling and treatment of diseases caused by Coxsackie and Coxsackie virus B3 with possible mechanism of action and role of phytochemicals -- Chapter 27: Phytochemical, clinical and preclinical studies focusing on use Indigenous plants against Cytomegalovirus, Cytomegalovirus B1 and Epstein-Barr virus infection: Prevalence and impact on patients with haematological diseases -- Chapter 28: Flavonoids: promising natural compounds against viral infections: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 29: Coumarins: emerging antiviral compounds from natural origin: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 30: Antiviral potential of Curcumins: Ethnopharmacology, chemistry, clinical studies focusing on mechanism of action and future perspectives..
This reference work covers general concepts of anti-viral metabolites, classifications, ethnopharmacology, chemistry, clinical and preclinical studies focusing on different medicinal plants against various types of viral infections. Various plants have been used in medicine since ancient times and are known for their strong therapeutic effects. The book will describe potential antiviral properties of medicinal plants against a diverse group of viruses, and provide an insight to the potential plants possess for broad-spectrum antiviral effects against emerging viral infections. The book aims to target a broad audience including virologists, molecular biologist, microbiologist and scientists working with natural products as well as researchers, students, healthcare experts involved in pharmaceutical and medical field..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2024. |
|---|---|
| Erschienen: |
Cham: Springer International Publishing ; 2024. Cham: Imprint: Springer ; 2024. |
| Ausgabe: |
1st ed. 2024. |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pal, Dilipkumar [HerausgeberIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Themen: |
Botanical chemistry. |
|---|
| Umfang: |
1 Online-Ressource(436 illus., 114 illus. in color. eReference.) |
|---|
| doi: |
10.1007/978-3-031-12199-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1869525647 |
|---|
| LEADER | 01000nam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1869525647 | ||
| 003 | DE-627 | ||
| 005 | 20231107112708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231107s2024 sz |||||o 00| ||eng c | ||
| 020 | |a 9783031121999 |9 978-3-031-12199-9 | ||
| 024 | 7 | |a 10.1007/978-3-031-12199-9 |2 doi | |
| 035 | |a (DE-627)1869525647 | ||
| 035 | |a (DE-599)KEP097142646 | ||
| 035 | |a (DE-He213)978-3-031-12199-9 | ||
| 035 | |a (EBP)097142646 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-CH | ||
| 072 | 7 | |a PNN |2 bicssc | |
| 072 | 7 | |a SCI013040 |2 bisacsh | |
| 245 | 1 | 0 | |a Anti-Viral Metabolites from Medicinal Plants |c edited by Dilipkumar Pal |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2024. | |
| 264 | 1 | |a Cham |b Imprint: Springer |c 2024. | |
| 300 | |a 1 Online-Ressource(436 illus., 114 illus. in color. eReference.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Reference Series in Phytochemistry | |
| 520 | |a Chapter 1 Introduction of medicinal plants as source of anti-viral metabolite(s), effects on health and general adverse effects -- Chapter 2:General plants showing anti-viral activity giving emphasis on CDRI’s biological screening programme -- Chapter 3: Classification of medicinal plants having anti-viral activity as per (i) family and (ii) types of viral infections -- Chapter 4: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 1 infections -- Chapter 5: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 2 infections -- Chapter 6: Role of various medicinal plants against in HIV infection in human with possible mechanism of action and functions of secondary metabolites -- Chapter 7: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of different medicinal plants against Hepatitis B infections -- Chapter 8: Antiviral effects of different medicinal plants against Hepatitis C (HCV) infection: Role of phytochemicals -- Chapter 9: Medicinal plants in controlling Pox virus affections:Ethnopharmacology, chemistry, clinical, preclinical studies and future perspectives -- Chapter 10: Role of medicinal plants in prevention and treatment of Respiratory viral infections -- Chapter 11: Assessment of effectiveness of herbal drugs in prevention and treatment against Gastrointestinal viral diseases -- Chapter 12: Antiviral potential of medicinal plants in treatment of diseases caused by Influenza virus A: Role of secondary metabolites, clinical and preclinical studies and future perspectives -- Chapter 13: Role of medicinal plants in treatment of diseases caused by Influenza virus B and Parainfluenza virus type 3 -- Chapter 14: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on the uses of herbal drugs against Polio Infections -- Chapter 15: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of medicinal plants against SARS-CoV/Corona virus infections -- Chapter 16: Medicinal plants in controlling and treatment of diseases caused by Viral Haemorrhagic Septicaemia Virus (VHSV) -- Chapter 17:Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against vesicular stomatitis virus (VSV) infections -- Chapter 18: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of various medicinal plants against Human Adenovirus Type 1 infections -- Chapter 19: Medicinal plants used by traditional medical practitioner in controlling and treatment of Cutaneous viral diseases: Ethnopharmacology, chemistry, Clinical and preclinical studies -- Chapter 20: Herbal drugs and medicinal plants in controlling and treatment for the diseases caused by Dengue virus (DEN-1 & 2): Ethnopharmacology, chemistry, clinical and preclinical studies -- Chapter 21: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of natural medicinal plants against Neurological viral diseases -- Chapter 22: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on traditional crude drugs against Encephalitis infection -- Chapter 23: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use natural plants in the treatment of Renal syndrome caused by viruses -- Chapter 24: Natural products in controlling and treatment of cancers and genital warts caused by different viruses -- Chapter 25: Role of traditional plants in controlling and treatment of fever, joint pain and pogosta diseases caused by viruses -- Chapter 26: Natural medicinal plants used in in controlling and treatment of diseases caused by Coxsackie and Coxsackie virus B3 with possible mechanism of action and role of phytochemicals -- Chapter 27: Phytochemical, clinical and preclinical studies focusing on use Indigenous plants against Cytomegalovirus, Cytomegalovirus B1 and Epstein-Barr virus infection: Prevalence and impact on patients with haematological diseases -- Chapter 28: Flavonoids: promising natural compounds against viral infections: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 29: Coumarins: emerging antiviral compounds from natural origin: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 30: Antiviral potential of Curcumins: Ethnopharmacology, chemistry, clinical studies focusing on mechanism of action and future perspectives. | ||
| 520 | |a This reference work covers general concepts of anti-viral metabolites, classifications, ethnopharmacology, chemistry, clinical and preclinical studies focusing on different medicinal plants against various types of viral infections. Various plants have been used in medicine since ancient times and are known for their strong therapeutic effects. The book will describe potential antiviral properties of medicinal plants against a diverse group of viruses, and provide an insight to the potential plants possess for broad-spectrum antiviral effects against emerging viral infections. The book aims to target a broad audience including virologists, molecular biologist, microbiologist and scientists working with natural products as well as researchers, students, healthcare experts involved in pharmaceutical and medical field. | ||
| 650 | 0 | |a Natural products. | |
| 650 | 0 | |a Botany. | |
| 650 | 0 | |a Botanical chemistry. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 700 | 1 | |a Pal, Dilipkumar |e herausgeberin |4 edt | |
| 776 | 1 | |z 9783031121982 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031121982 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-12199-9 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 912 | |a ZDB-2-SEB |b 2024 | ||
| 912 | |a ZDB-2-CMS |b 2024 | ||
| 912 | |a ZDB-2-SXRP |b 2024 | ||
| 912 | |a ZDB-2-SXCH |b 2024 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a ISIL_DE-830 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a ISIL_DE-705 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a ISIL_DE-700 | ||
| 912 | |a GBV_ILN_132 | ||
| 912 | |a ISIL_DE-959 | ||
| 912 | |a GBV_ILN_153 | ||
| 912 | |a ISIL_DE-Ha94 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a ISIL_DE-90 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a ISIL_DE-93 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 912 | |a GBV_ILN_2020 | ||
| 912 | |a ISIL_DE-Ch1 | ||
| 912 | |a GBV_ILN_2027 | ||
| 912 | |a ISIL_DE-105 | ||
| 912 | |a GBV_ILN_2034 | ||
| 912 | |a ISIL_DE-Rt2 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a ISIL_DE-944 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 547 | ||
| 980 | |2 23 |1 01 |x 0830 |b 442191181X |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h olr-springer |u i |y z |z 29-11-23 | ||
| 980 | |2 60 |1 01 |x 0705 |b 440866541X |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h SpringerLink |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |k Nur für Angehörige der HSU: Volltextzugang von außerhalb des Campus mit Anmeldung über Shibboleth mit Ihrer Bibliothekskennung |y z |z 16-11-23 | ||
| 980 | |2 62 |1 01 |x 0028 |b 4442415943 |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 20-12-23 | ||
| 980 | |2 65 |1 01 |x 0003 |b 4447247852 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-CMS |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 04-01-24 | ||
| 980 | |2 120 |1 01 |x 0715 |b 4454059780 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 11-01-24 | ||
| 980 | |2 130 |1 01 |x 0700 |b 4453857799 |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 11-01-24 | ||
| 980 | |2 132 |1 01 |x 0959 |b 4493380543 |h OLR-ESP-CMS |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k |z 28-02-24 | ||
| 980 | |2 153 |1 01 |x 3315 |b 4489892241 |h OLR-ESP |k Full text access is limited to MPI staff and may be printed or saved solely for private use or for research purposes. You are not allowed to pass articles (electronically or printed) to a third party. Systematic download is prohibited |y z |z 21-02-24 | ||
| 980 | |2 2014 |1 01 |x DE-90 |b 444803190X |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 04-01-24 | ||
| 980 | |2 2015 |1 01 |x DE-93 |b 4467423745 |c 00 |f --%%-- |d --%%-- |e --%%-- |j p |k Campuslizenz |y l01 |z 24-01-24 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 4403679161 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 07-11-23 | ||
| 980 | |2 2020 |1 01 |x DE-Ch1 |b 443431291X |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |k Campuslizenz |y l01 |z 13-12-23 | ||
| 980 | |2 2027 |1 01 |x DE-105 |b 4440020739 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Campuslizenz |y l01 |z 18-12-23 | ||
| 980 | |2 2034 |1 01 |x DE-Rt2 |b 4442668647 |c 00 |f --%%-- |d eBook |e --%%-- |j n |k Zugriff von allen im Hochschulnetz befindlichen Rechnern; Hochschulangehörige können auch über VPN von außerhalb des Campusnetzes zugreifen |y l01 |z 21-12-23 | ||
| 980 | |2 2111 |1 01 |x DE-944 |b 4460904780 |c 00 |f --%%-- |d E-Book Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 18-01-24 | ||
| 981 | |2 23 |1 01 |x 0830 |y Springer EBook |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 60 |1 01 |x 0705 |y Volltextzugang Campus |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016357568503501 | ||
| 981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 132 |1 01 |x 0959 |y Zugriff nur für Angehörige der Hochschule Osnabrück im Hochschulnetz |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 153 |1 01 |x 3315 |y Springer EBook |r https://doi.org/10.1007/978-3-031-12199-9?nols=y | ||
| 981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 2020 |1 01 |x DE-Ch1 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 2034 |1 01 |x DE-Rt2 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 981 | |2 2111 |1 01 |x DE-944 |r https://doi.org/10.1007/978-3-031-12199-9 | ||
| 982 | |2 132 |1 01 |x 0959 |8 00 |a EBooks Springer Chemistry & Materials Science | ||
| 982 | |2 2027 |1 01 |x DE-105 |8 00 |s s |a ebook | ||
| 983 | |2 2111 |1 01 |x DE-944 |8 00 |0 (DE-627)1353370437 |a e-Book | ||
| 995 | |2 23 |1 01 |x 0830 |a olr-springer | ||
| 995 | |2 60 |1 01 |x 0705 |a SpringerLink | ||
| 995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-CMS | ||
| 995 | |2 120 |1 01 |x 0715 |a alma | ||
| 995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP-CMS | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP | ||
| 995 | |2 153 |1 01 |x 3315 |a OLR-ESP | ||
| 998 | |2 23 |1 01 |x 0830 |0 2023.11.29 | ||